Literature DB >> 7572993

Hydroxyurea: an alternative to transfusion therapy for stroke in sickle cell anemia.

R E Ware1, M H Steinberg, T R Kinney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572993     DOI: 10.1002/ajh.2830500211

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).

Authors:  Russell E Ware; Ronald W Helms
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

Review 2.  Stroke in children with sickle cell anaemia: aetiology and treatment.

Authors:  C H Pegelow
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Hemodynamic responses to visual stimulation in children with sickle cell anemia.

Authors:  Ping Zou; Kathleen J Helton; Matthew Smeltzer; Chin-Shang Li; Heather M Conklin; Amar Gajjar; Winfred C Wang; Russell E Ware; Robert J Ogg
Journal:  Brain Imaging Behav       Date:  2011-12       Impact factor: 3.978

Review 4.  Sickle cell disease in Africa: burden and research priorities.

Authors:  J Makani; T N Williams; K Marsh
Journal:  Ann Trop Med Parasitol       Date:  2007-01

5.  Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or Fact.

Authors:  Sawsan M Moeen; Ahmad F Thabet; Hosam A Hasan; Medhat A Saleh
Journal:  Indian J Hematol Blood Transfus       Date:  2017-04-08       Impact factor: 0.900

Review 6.  Sickle cell disease: new opportunities and challenges in Africa.

Authors:  J Makani; S F Ofori-Acquah; O Nnodu; A Wonkam; K Ohene-Frempong
Journal:  ScientificWorldJournal       Date:  2013-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.